Recent research focusing on Retatrutide at a dosage of 30mg is shedding new light on its potential benefits. Preliminary findings suggest that this higher dosage may boost the drug's ability to manage blood levels, potentially offering more significant outcomes for individuals with insulin resistance. Further study is underway to fully explore the